Kapila Hasso Viges is an operating executive with expertise in starting, building, and scaling life science and healthcare organizations transitioning from clinical to commercial operations. Kapila has specific expertise in therapeutic and diagnostic product development, launch, and commercialization strategy in oncology and rare diseases. Earlier in her career, Kapila gained extensive experience in technology transfer, intellectual property management, and high-tech and biotech startup incubation. Kapila has enabled the start-up of dozens of biomedical companies, raised seed and growth capital investments from both non-dilutive and equity funds, and been principal and portfolio lead of life science equity funds.
Kapila has developed unique expertise in leveraging partnerships at the intersection of academia, public & philanthropic sectors, industry, and capital markets, to advance biomedical innovations to the clinic and eventually through the approval and access lifecycle. Currently serving as chief executive of the MPN Research Foundation, Kapila is advancing patient-centric research to uncover new understandings of blood cancers towards new treatments and better outcomes for patients.
Kapila has a B.S. in Materials Science and Engineering from Johns Hopkins University and is an Executive Scholar from Kellogg School of Business at Northwestern University.
